The Ukrainian health care market has undergone a range of changes since 2016. The medical system reform was launched at the beginning of 2018. It started from the primary health care change. Therefore, the state policy aims to create optimal conditions of first aid administration and to stimulate the operation of the doctors of the primary health care staff in the health system. The important peculiarity of development of the public health is a reduction in number of hospitals and increase in number of medical outpatient facilities.
At year end-2015 and 2016, the market of paid medical services grew in money terms. According to the official data, the odontology and diagnostics are in demand in the private sector structure.
The share of hospital sector has increased in physical terms in the Ukrainian pharmaceutical market over the past two years (in 2016 and 2017). The state policy in this sphere aims to attract the foreign investments in order to develop the pharmaceutical branch in general. The local market participants increase the market share in the production and sale of pharmaceuticals at the expense of the price factor.
1. Ukrainian health system
Ukrainian health care market size
Market of paid medical services. Private sector
Medical insurance system
State policy in the field of health care
2. Ukrainian pharmaceutical market
Ukrainian pharmaceutical market size in 2016-2017
Production of pharmaceuticals
Ukrainian foreign trade in pharmaceuticals
3. Pharmaceutical management policy in Ukraine
Registration of drugs
Fast-track review process for pharmaceuticals
Preparation of the regulatory documents
Local QC testing
Registration of brand names of pharmaceuticals
5. Public procurement of pharmaceuticals (ARV drugs)
New public authority specialized in pharmaceuticals procurement in Ukraine in 2019-2020
Methods used to forecast the pharmaceuticals domestic demand
Qualification requirements for the tenderers
Tendering process. Factors influencing the selection of a supplier
Procurement process, delivery conditions
Process of distribution of purchased drugs in the country
Import substitution policy. Main pharmaceutical market participants (including ARV drugs)
List of ARV drugs for procurement
6. Ukrainian market of ARV drugs
COST: USD 4,520.00
The US Congress approved the 2020 Bill of Belarusian Democracy, Human Rights and Sovereignty.
In January-September 2020, the GDP of Belarus amounted to BYN 106.6 billion, or in comparable prices 98.7% over the same period in 2019. In addition to the coronavirus epidemic and two currency crises, the main impact on the economic decline was made by the decrease in turnover in the petrochemistry and mechanical engineering.
Among other obvious factors, the protests in Belarus were the result of global changes in the economy. The old model, the tangible industrial one, is more and more moving aside, and it is being replaced by a new, information technology model generally known as postindustrial.
In 2020, the Belarusian economy experienced several disturbances: a decrease in the Russian crude supplies, the pandemic consequences, and two foreign exchange crises in March and August. As a result, the GDP of Belarus in January-July 2020 amounted to BYN 80.0 billion, or 98.4% in comparable prices compared with the same period in 2019.
In January-March 2020, Belarus; GDP amounted to 99.7% in comparable prices as against January-March 2019. Although Belarus' GDP gradually began to win back the January fall in February-March of this year, the index is nevertheless decreasing.